SEMAGLUTIDE : ONE THOROUGH REVIEW

The novel class of GLP-1 receptor agonist and GIP co-agonist medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, provide promising advances in metabolic control. Despite all three function by influencing sugar readings , they distinguish in their unique mechanisms